- Research article
- Open Access
The role of the C8 proton of ATP in the catalysis of shikimate kinase and adenylate kinase
© Kenyon and Roth; licensee BioMed Central Ltd. 2012
- Received: 11 November 2011
- Accepted: 26 July 2012
- Published: 10 August 2012
It has been demonstrated that the adenyl moiety of ATP plays a direct role in the regulation of ATP binding and/or phosphoryl transfer within a range of kinase and synthetase enzymes. The role of the C8-H of ATP in the binding and/or phosphoryl transfer on the enzyme activity of a number of kinase and synthetase enzymes has been elucidated. The intrinsic catalysis rate mediated by each kinase enzyme is complex, yielding apparent KM values ranging from less than 0.4 μM to more than 1 mM for ATP in the various kinases. Using a combination of ATP deuterated at the C8 position (C8D-ATP) as a molecular probe with site directed mutagenesis (SDM) of conserved amino acid residues in shikimate kinase and adenylate kinase active sites, we have elucidated a mechanism by which the ATP C8-H is induced to be labile in the broader kinase family. We have demonstrated the direct role of the C8-H in the rate of ATP consumption, and the direct role played by conserved Thr residues interacting with the C8-H. The mechanism by which the vast range in KM might be achieved is also suggested by these findings.
We have demonstrated the mechanism by which the enzyme activities of Group 2 kinases, shikimate kinase (SK) and adenylate kinase 1 (AK1), are controlled by the C8-H of ATP. Mutations of the conserved threonine residues associated with the labile C8-H cause the enzymes to lose their saturation kinetics over the concentration range tested. The relationship between the role C8-H of ATP in the reaction mechanism and the ATP concentration as they influence the saturation kinetics of the enzyme activity is also shown. The SDM clearly identified the amino acid residues involved in both the catalysis and regulation of phosphoryl transfer in SK and AK1 as mediated by C8H-ATP.
The data outlined serves to demonstrate the “push” mechanism associated with the control of the saturation kinetics of Group 2 kinases mediated by ATP C8-H. It is therefore conceivable that kinase enzymes achieve the observed 2,500-fold variation in KM through a combination of the various conserved “push” and “pull” mechanisms associated with the release of C8-H, the proton transfer cascades unique to the class of kinase in question and the resultant/concomitant creation of a pentavalent species from the γ-phosphate group of ATP. Also demonstrated is the interplay between the role of the C8-H of ATP and the ATP concentration in the observed enzyme activity. The lability of the C8-H mediated by active site residues co-ordinated to the purine ring of ATP therefore plays a significant role in explaining the broad KM range associated with kinase steady state enzyme activities.
- Nucleotide Binding Site
- Kinetic Isotope Effect
- Conserve Amino Acid Residue
- Phosphoryl Transfer
- Shikimate Kinase
It has been demonstrated that the adenyl group of ATP plays a direct role in the control of ATP binding and/or phosphoryl transfer within a range of kinase and synthetase enzymes [1, 2]. The role of the ATP C8-H in the binding and/or phosphoryl transfer activity of a number of kinase and synthetase enzymes was elucidated in comparative enzyme activity assays using ATP and ATP deuterated at the C8 position. These comparisons demonstrated that a primary kinetic isotope effect (KIE) was involved in all cases.
Historically, the kinases have been classified into 25 families of homologous proteins, with the families assembled into 12 fold-groups based on the similarity of their structural folds [3, 4]. This classification relays little information on the catalytic mechanisms employed in nucleotide binding and phosphoryl transfer. The functionality required for the catalysis and regulation of phosphoryl transfer was found to be conserved within the families or fold-groups. As a result, a number of conserved mechanisms were proposed, wherein the C8-H of the adenyl moiety was found to play a direct role in the control of phosphoryl transfer . These mechanisms were developed using structurally conserved amino acid residues within hydrogen-bonding distance of a nucleotide in the active sites of crystallised kinases of a particular mechanistic class. On the basis of these conserved mechanisms, the role of the nucleotide C8-H in initiating the formation of a pentavalent phosphorus intermediate from the γ-phosphate of ATP and the substrate nucleophile was defined. All the kinase mechanistic classes were clustered into two proposed mechanisms depending on how the C8-H is induced to be labile, namely by either the co-ordination of a backbone carbonyl to C6-NH2 of the adenyl moiety (a “push” mechanism), or based on the protonation of N7 of the adenyl moiety (a “pull” mechanism). Associated with both the “push” and “pull” mechanisms is a proton transfer cascade via the tri-phosphate backbone, initiated from C8-H, and mediated by specific conserved amino acid residues unique to a particular mechanistic “class” of kinases, that culminates in a pentavalent species formed between the γ-phosphate of ATP and the substrate nucleophile. The “push” mechanism was defined within the Group 2 kinases . The Group 2 kinases are based on the kinase organization outlined by Cheek et al. ).
Two examples of enzymes falling within the Group 2 kinases are Mycobacterium tuberculosis shikimate kinase (SK) and human adenylate kinase 1 (AK1). SK belongs to the nucleoside monophosphate (NMP) kinase structural family, a sub-family of the P-loop containing nucleoside tri-phosphate hydrolase superfamily (Pfam Clan: AAA:CL0023) . The shikimate pathway is a seven-step biosynthetic route that links the metabolism of carbohydrates to the synthesis of aromatic amino acids by the conversion of erythrose-4-phosphate to chorismic acid . SK (EC 22.214.171.124), the fifth enzyme in the shikimate biosynthetic pathway, catalyzes phosphate transfer from ATP to the 3-hydroxy group of shikimate, forming shikimate-3-phosphate. Adenylate kinases (AKs) contribute to the homeostasis of adenine nucleotides by maintaining intracellular nucleotide pools. Six isoenzymes of adenylate kinase have been identified in mammalian cells with different subcellular localization and substrate specificity [7, 8]. The AKs (ATP:AMP phosphotransferases, EC 126.96.36.199) catalyse the reversible transfer of the γ-phosphate group from a phosphate donor (ATP, GTP, CTP, ITP) to ADP, with the phosphate donor usually ATP. AK1 also belongs to the P-loop containing nucleoside tri-phosphate hydrolase superfamily (Pfam Clan: AAA:CL0023). There is a size variation among the isoenzymes: AK1, AK5 and AK6 are short type AKs, while AK2, AK3 and AK4 are long type AKs that contain a 27 amino acid insertion sequence in the central portion of the protein . The mammalian AKs have a distinct intracellular compartmentalization, with AK1 in the cytosol, AK2 in the intermembrane space of mitochondria, AK3 in the mitochondrial matrix, AK4 being mitochondrial in nature, AK5 (unknown) and AK6 in the nucleus [9–15].
SDM of SK and AK1
Catalytic residues associated with phosphoryl transfer
Interatomic distance (Å)
Interatomic distance (Å)
Interatomic distance (Å)
1. C8-H to α-PO4
2. αC = O to C6-NH2
3. Thr-OH to C8H
4. Thr-OH to α-PO4
5. Arg-NH1 to C8
7. Lys- γ-PO4
Steady state specific activities of SK and AK1, WT and mutant enzymes
Specific activity 1
1. Wild type
10. Lys- γ-PO4
Effect of C8D-ATP on specific activity of Thr mutants
Kinetic parameters of wild-type and mutant variants of SK and AK1
Kcat (s -1)
Kcat/Km (s-1 M -1)
1. SK WT ATP (M-M)
6.533 6.53 ± 3.25
0.0484 233.8 ± 60.58
4.841 × 103
8.749 × 102
2. SK WT d-ATP (M-M)
12.74 19.26 ± 7.00
0.0503 333.4 ± 89.2
5.027 × 103
3.946 × 102
3. SK-T17I ATP (A-S)
Ambig 30.73 ± 2.17
Ambig 43.94 ± 3.87
4. SK-T17I d-ATP (M-M)
22.05 ± 10.47 6.22 ± 3.57
0.0333 25.03 ± 7.70
1.331 × 103
5. SK-K15I ATP (M-M)
4.054 4.13 ± 1.72
0.0057 2.736 ± 0.054
5.664 × 10
1.397 × 10
6. SK-K15I d-ATP (A-S)
1.091 0.754 ± 0.227
0.0023 0.971 ± 0.031
2.369 × 10
2.171 × 10
7. AK1 WT ATP1 (A-S)
6.649 × 103
3.479 × 103
8. AK1 WT d-ATP (M-M)
7.583 × 103
1.875 × 103
9. AK1-T23V ATP (M-M)
4.497 × 104
3.483 × 103
10. AK1-T23V d-ATP (M-M)
2.919 × 104
2.777 × 103
11. AK1-R128A ATP
12. AK1-R128A d-ATP
13. AK1-T39V ATP (A-S)
1.989 × 103
3.626 × 102
14. AK1-T39V d-ATP (M-M)
7.972 × 102
2.464 × 102
15. AK1-R97A ATP (A-S)
6.527 × 102
5.323 × 103
16. AK1-R97A d-ATP (M-M)
1.605 × 102
The SK-T17I mutant has significantly less activity than WT SK (Figure 3). WT SK showed a classical KIE, with the kinetic data reaching an asymptote at about 2 with decreasing ATP concentration, and a similar asymptote at 1 with increasing ATP concentration (Figure 4). It is interesting to note that the KIE is inverted in SK-T17I, with C8D-ATP yielding a higher specific activity than ATP (Figures 3 and 4). These inverted responses manifest in the Km values, with the WT SK Km for ATP and C8D-ATP being 6.533 and 12.74 mM, respectively, while the SK-T17I Km for C8D-ATP was found to be 22.05 mM. The SK-T17I Km could not be calculated for ATP as the response to the change in ATP concentration is linear (see discussion). The change in specificity of SK-T17I is clearly shown by the Kcat/Km values for ATP and C8D-ATP. For WT SK, these are 8.75 × 102 and 3.95 × 102 s-1.M-1, respectively, while the Kcat/Km for C8D-ATP for SK-T17I is 60.06 s-1.M-1.
The enzyme activity profile of the AK1-T23V mutant varies significantly from WT AK1 (Figure 5). There is no inversion of the KIE with C8D-ATP, as seen in the SK-T17I mutant. However, there is a significant increase in vmax (Figure 5, Table 3). The vmax of WT AK1 for ATP and C8D-ATP was 141.7 and 557.7 μmol.min-1.(mg protein)-1, respectively, while the vmax for ATP and C8D-ATP for AK1-T23V is 1,850 and 1,062 μmol.min-1.(mg protein)-1, respectively. These responses also manifest in the Km, with the Km for ATP and C8D-ATP for WT-AK1 being 1.911 and 4.043 mM, respectively, while those for AK1-T23V are 12.91 and 10.51 mM, respectively. There is little change in the specificity of AK1-T23V, as shown comparing the WT AK Kcat/Km values for ATP (3.749 × 103 s-1.M-1) and C8D-ATP (1.875 × 103 s-1 M-1), with those for AK1-T23V (3.483 × 103 s-1.M-1 for ATP and 2.777 × 103 s-1 M-1 for C8D-ATP). The change in specificity within each enzyme therefore follows a classical KIE, with C8D-ATP giving a lower Kcat/Km relative to ATP.
The enzyme specific activity obtained for AK1-T39V was also significantly less than that obtained for WT AK1 (Figure 5). The vmax of AK1 for ATP and C8D-ATP was 141.7 and 557.7 μmol.min-1.(mg protein)-1, respectively, while those for AK1-T39V are 29.57 and 39.21 μmol.min-1.(mg protein)-1, respectively. These responses are reflected in the Km values for WT AK1 in the presence of ATP and C8D-ATP being 1.911 and 4.043 mM, respectively, while those for AK1-T39V were 5.485 and 3.235 mM, respectively. The change in the specificity of AK1-T39V is shown by the Kcat/Km values for ATP and C8D-ATP, with those for WT AK being 3.479 × 103 and 1.875 × 103 s-1.M-1, respectively, while the Kcat/Km for ATP and C8D-ATP for AK1-T39V is 3.626 × 102 and 2.464 × 102 s-1.M-1, respectively. The change in specificity therefore follows a classical KIE, with C8D-ATP giving a lower Kcat/Km relative to ATP.
The KIE effect for WT AK1 is high (KIE > 2) at very low ATP concentrations, and then tends towards approximately 1 as the specific activity tends towards vmax (Figures 5 and 6). In contrast, the KIED for AK1-T23V is low at low ATP concentrations, with the KIE remaining constant over the ATP concentration range (Figures 5 and 6). The KIE and KIED of AK1-T39V is essentially the same as that obtained for WT AK1. The major effect of the T39V mutation is a significant loss in the overall enzyme activity.
Effect of C8D-ATP on specific activity of Thr and Lys mutants
The SK-K15I mutation caused an approximately 100-fold reduction in enzyme activity (Figure 3, Table 3). The vmax of WT SK for ATP and C8D-ATP was 233.8 and 333.4 μmol.min-1.(mg protein)-1, respectively, while those for SK-K15I were 2.736 and 0.971 μmol.min-1.(mg protein)-1, respectively. The change in the specificity of the SK-K15I enzyme is shown by the Kcat/Km values for ATP and C8D-ATP for the WT SK being 8.749 × 102 and 3.946 × 102 s-1.M-1, respectively, while those for SK-K15I is 1.397 × 10 and 2.171 × 10 s-1.M-1, respectively. The specific enzyme activity obtained for SK-R110A was too low to allow accurate kinetic constants to be obtained.
The AK1-R97A and AK1-R128A mutations caused a significant loss in the overall enzyme activity (Figures 5 and 6). The vmax of WT AK1 for ATP and C8D-ATP was 141.7 and 557.7 μmol.min-1.(mg protein)-1, respectively, while the vmax for ATP and C8D-ATP for AK1-R97A is 2.532 and 4.388 μmol.min-1.(mg protein)-1, respectively. These responses manifest in the Km for ATP and C8D-ATP with those for WT AK1 being 1.911 and 4.043 mM, respectively, while the Km for ATP and C8D-ATP for AK1-R97A is 0.002 and 0.460 mM, respectively. The low activities obtained for both the AK1-R97A and The AK1-R128A enzymes did not allow for the accurate determination of the Kcat, suffice to say that both mutations had a significant impact on the overall reduction of the enzyme activity. The AK1-R128A enzyme gave a linear response in enzyme activity to the change in the ATP or C8D-ATP concentration (Figure 5).
The threonine residues associated with the proton transfer from C8-H to the α-PO4 for both enzymes are Thr17 for SK, and Thr23 and Thr39 for AK1, SK-Thr17 and AK1-Thr23 appear to function as response elements towards ATP concentration in, and saturation of, the enzyme. The AK1-Thr39 has a purely hydrogen bonding role and does not appear to play a catalytic role in the creation of the pentavalent phosphorus intermediate between the ATP and the AMP. It may, however, serve to regulate the reverse reaction from 2ADP to ATP and AMP. This is shown by the varying responses to the Thr mutation, where the SK-Thr17 and the AK1-Thr23 mutations do not destroy the enzyme function but merely change the response of the enzymes to varying ATP and C8D-ATP concentrations, while the AK1-Thr39 mutation destroys functionality. The effect of deuteration of ATP on the activity and kinetic constants for the SK-T17I mutant was to invert the KIE obtained. The KIE for the WT SK enzyme was a classical (mass dependent) primary KIE (KIE ≈ 2 with decreasing ATP concentration, and asymptoting to 1 with increasing ATP concentration). The inverse KIE (KIED) tends towards 0.5 at low ATP concentrations, approaching 1 with increasing ATP concentration. This trend is, however, inverted for the SK-T17I mutant enzyme where the KIED tends towards 2 with decreasing ATP concentration, while approaching 1 with increasing ATP concentration. The deuteration therefore functions in much the same manner as the Thr17 residue. The deuterium functions by increasing the lifetime of the pentavalent phosphorus species, increasing the probability for phosphorylation of the substrate. Another effect of the SK-T17I mutation is in the response of the enzyme to changing ATP concentrations. In this instance, over the concentrations used in the assays, a linear response is obtained to changing concentration is seen as opposed to a classical hyperbolic response. This demonstrates that the SK-T17I enzyme activity is based purely on an ATP concentration-dependent first order rate equation. The mechanistic role the Thr17 residue plays rests in the effective transfer of the proton from C8-H to the α-PO4, as part of the direct in-line mechanism of phosphoryl transfer culminating in the pentavalent phosphorus species (Figure 9). The rate of phosphoryl transfer is, therefore, based on two factors: (i) the concentration of ATP, and (ii) the induced lability of the C8-H (reflected in its apparent pKa) and subsequent proton transfer in the creation of the pentavalent transition state. At low ATP concentrations, the activity of the enzyme is predominantly governed by the release of the C8-H from ATP. As the ATP concentration increases, the role of the ATP concentration in activity begins to dominate. In the case of the WT SK enzyme, the net result of this is that the KIE is at its highest at low ATP concentrations. As the concentration effect takes over, the KIE is reduced. In the case of SK-T17I, the C8D-ATP functions more efficiently than the ATP, as the deuteration serves to increase the lifetime of the pentavalent transition state, thereby increasing the probability for the overall reaction. As the ATP concentration tends towards zero, the role of T17 in catalysis is at its maximum. As the concentration of ATP is increased, the effect of concentration on the specific activity of WT SK increases. This is borne out by the effect of ATP concentration on the activity of the SK-T17I enzyme, which shows an ATP-dependent first order response. The perceived specific activity of a particular kinase in response to varying ATP concentration is therefore dependent on the relative impacts of C8-H lability and the first order ATP concentration effect.
Examination of the data for WT AK1 indicates significant difference in the Km values for ATP and C8D-ATP (Table 3). The Km values for ATP and C8D-ATP for AK1-T23V were, however, similar. Deuteration significantly increases the vmax of the WT AK1 enzyme (Figure 5, Table 3). The major difference that occurs is the impact of the mutation on vmax, with vmax of 141.7 for WT AK1 increasing to 1,850 for AK1-T23V in the presence of ATP, and a similar increase in vmax from 557.7 for WT AK1 to 1,062 for AK1-T23V in the presence of C8D-ATP. As also occurs in the case of SK, the mutation in the Thr residue in AK1 significantly increases the Km of the enzyme. Another effect of the AK1-T23V mutation is in the response of the enzyme to changing ATP concentrations where, over the concentrations used in the assays, a classical hyperbolic response is not obtained and instead an almost linear response is obtained to changing concentration (Figure 5). It has been proposed that in certain kinase reactions, the protonation of the α-PO4 may occur directly from C8-H without the need of a carrier side-chain . Here, it is proposed that for both the SK-T17I and AK1-T23V mutant enzymes, the proton transfer could occur directly from the C8-H to the α-PO4, albeit with reduced impact on the activity. Alternatively, the role could be fulfilled by adventitious H2O. The impact of H2O in place of the Thr hydroxy moeity would probably be concentration dependent. In the case of AK1-T23V, this may be the case, since this mutation brings about an increase in the overall activity of the enzyme. The AK1-T23V mutation does not change the specificity of the enzyme for the substrate; the influence of the Thr hydroxy group is lacking at high concentration for this mutant, however. In the case of SK-T17I, the use of C8D-ATP effectively mimics the presence of a functional T17 by stabilizing the transition state intermediate and increasing the probability of the reaction occurring, mimicking the role of the Thr hydroxy group. The loss of the interplay between the role of the Thr hydroxy group and the variation in ATP concentration due to the AK1-T23V mutation resulted in an increase in the vmax. In effect, the AK1-T23V mutation merely causes this enzyme to respond in a linear first order manner to the change in the ATP concentration. The steady state enzyme activity is therefore achieved by the interplay between the two effects, namely the role of the pKa of the C8-H and the role of the ATP concentration. In the case of the Thr mutations, H2O probably fulfills the role of the Thr hydroxy group and the impact of the mutation is dependent on the H2O concentration. In the case of SK, the availability of water to fulfill this role is lower than in the case of AK1 (as seen by the decreased overall the steady state activity of the mutant). In WT AK1, the role of Thr23 predominates at low ATP concentrations, while increasing ATP concentration steadily diminishes the importance of this role in favour of mass action. Mutant AK1-T39V enzyme appears to have lost most of its functionality (Figure 5, Table 3). The second nucleotide binding site appears to function via the “pull” mechanism, with the Thr39 serving to protonate AMP N7 - an intrinsic part of the “pull” mechanism . Once this occurs, the lone pair on the nitrogen of Arg97 serves stabilize the incipient carbene which is forming at C8 of ATP (Figure 10). Removal of the Thr39 therefore destroys the functionality, even if the C8-H of the ATP is in close enough proximity of the α-PO4. This is because Thr39 assists this protonation event by increasing the lability of ATP C8-H in the process of stabilising the nascent carbene that forms in the “pull” mechanism. Both the R128A and the R97A mutant enzymes have significantly reduced enzyme activities, with vmax values of 2.532 and 4.597 respectively (Figure 6, Table 3). The Arg128, which functions in conjunction with Thr23, serves to protonate C8 and stabilize the carbene. Furthermore, Arg97, which functions in conjunction with Thr39, plays a key role in the formation of the carbene in the “pull” mechanism. If the C8-H of AMP was playing a direct role in the regulation of AK1 enzyme activity, a KIE should be obtained on comparison of the activity between enzyme activities obtained in the presence of AMP and C8D-AMP. This was, however, not found to be the case as AMP deuterated at the C8 position had no effect on the specific enzyme activity (Additional file 1: Figure S1).
Taking these observations into account, it should be borne in mind that the conformational changes arising on nucleotide binding within the P-loop containing nucleoside triphosphate hydrolase superfamily allow the residues of the conserved Walker A motif to “lock” the phosphate backbone into position [18, 19]. As a result, two residues that form part of the consensus sequence, GXXXXGKT/S, are brought directly into play, mechanistically speaking. Significantly, these residues also play an integral part of the “push” mechanism in the guise of the conserved Thr residue coordinated to C8-H proton and the Lys residue responsible for the proton transfer between the α- and β-phosphates. The catalytic role of the conserved Thr residue has previously been identified, including its hydrogen bonding interaction via the Thr-OH…O-Pα(ATP) . [Shi et al. (1993]), in fact, ask the question, “How can Thr-23 participate in catalysis by interacting with the α-phosphate of ATP but not contribute to the energetics of catalysis?” This research demonstrates that the C8-H…HO-Thr and Thr-OH…O-Pα(ATP) interactions play a role in the initiation of phosphoryl transfer and that the Thr residue, effectively, acts as a molecular “switch” on completion of nucleotide and substrate binding. As a result, the phosphoryl transfer occurs, via the classical in-line mechanism [21–23]. This in-line associative SN2 type mechanism of phosphoryl transfer is pertinent to this reaction mechanism as the phosphoryl transfer is dependent on the formation of a pentavalent phosphorus intermediate between the γ-phosphate and the substrate nucleophile.
The steady-state enzyme activity in the kinase enzymes is obviously more complex than merely the phosphorylation of a substrate nucleophile. This complexity is apparent in the broad range of KM constants of the kinases ranging from less than 0.4 μM to in excess of 1,000 μM for ATP (Carna Biosciences, Inc., Kinase Profiling Book: http://www.carnabio.com). The kinase enzymes have been classified into 25 families of homologous proteins, with the families assembled into 12 fold-groups based on the similarity of their structural folds, as well as conserved mechanisms associated with the regulation of the enzyme activity via the C8-H of the adenyl moiety [2–4]. Within a single group, both prokaryotic and eukaryotic organisms are represented with kinase isoenzymes that appear to be kinetically and functionally distinct based on the rate of phosphoryl transfer and the regulation thereof. It is therefore conceivable that the various conserved “push” and “pull” mechanisms associated with the release of C8-H, the proton transfer cascades and the resultant/concomitant creation of the pentavalent transition state are the mechanisms by which the kinase enzymes achieve this 2,500-fold variation in the KM. Polyphosphate could serve as the energy “currency” within the cell however, ATP fulfils this role. It is necessary that the kinase enzymes carry out their specific reactions at differential rates and to achieve these varying rates the kinases have evolved a number of conserved mechanisms which broadly manifest in the “push” and the “pull mechanisms”. Data outlined above serves to demonstrate the “push” mechanism associated with the role of the C8-H in the regulation of the Group 2 kinases. The phosphoryl transfer mechanism found in the Group 2 kinases (Rossmann-like fold and phosphoenolpyruvte carboxykinase-like sequences) was assessed using M. tuberculosis shikimate kinase and human adenylate kinase as the model systems. The initiation of phosphoryl transfer in SK occurs via the co-ordination of the ATP C6-NH2 to a carbonyl arising from the protein backbone by the “push” mechanism, resulting in the protonation of C8 via the co-ordination of a conserved Arg residue (Arg110). This renders the C8-H more acidic, allowing for the protonation of the α-PO4 via the hydroxyl of the conserved Thr carrier (Thr17). There is a concomitant transfer of an proton from the α-PO4 to β-PO4 via Arg117, thereby facilitating the formation of the pentavalent intermediate between the γ-PO4 and the substrate nucleophile. Where required, there is a simultaneous ATP-mediated deprotonation of the substrate -OH, allowing for the nucleophilic attack by the substrate to create the pentavalent intermediate and allowing phosphoryl transfer. In the case of adenylate kinase, the substrate is acidic, which does not require deprotonation. The protonated Lys15 then transfers the proton to the γ-PO4, changing the Mg2+ from being β-PO4 to γ-PO4 co-ordinated to being α-PO4 to β-PO4 co-ordinated. The proton originally arising from the C8 is then transferred back to C8, allowing the electron density of the adenyl moiety to return to the “ground-state” distribution. The human AK1 has two nucleotide binding sites and the second site may utilise the “pull” mechanism as outlined by Kenyon et al. . The “pull” mechanism is the phosphoryl transfer mechanism found in the Group 4 kinases (hexokinase family with polyol substrate). The initiation of phosphoryl transfer occurs via the coordination of the ATP C6-NH2 to a carbonyl arising from the protein backbone by the “push” mechanism, resulting in the protonation of C8 via the co-ordination of a conserved Arg (Arg128). This renders the C8-H more acidic, allowing for the protonation of the α-PO4, via the hydroxyl of the conserved Thr carrier (Thr23). There is a concomitant transfer of a proton from the α-PO4 to the γ-PO4 via the conserved Arg132, thereby facilitating the formation of the pentavalent intermediate between the γ-PO4 and the substrate nucleophile, in this case the α-PO4 of the AMP in the second site. The AMP in the second nucleotide binding site is activated by the protonation of AMP-N7 via the conserved Thr39, forming a carbene on the imidazole moiety that causes a change in C8 hybridization from sp2 to sp3. The carbene is stabilized by the lone pair on the co-ordinated Arg97 residue. The nucleophilic attack from the oxygen on the α-PO4 of AMP creates the pentavalent intermediate and allows phosphoryl transfer. The proton originally arising from the C8 is then transferred back to C8, allowing the electron density of the adenyl moiety to return to the “ground-state” distribution. The reaction occurs via a carbene mechanism, with the carbene being stabilized via the interaction of a conserved Arg97 within hydrogen bonding distance of C8, causing C8-H to become more acidic, thereby allowing for the protonation of the α-PO4 via a conserved Arg97. There is a concomitant transfer of a proton from the α-PO4 to the γ-PO4 via a conserved Arg132, facilitating the formation of the pentavalent intermediate between the γ-PO4 and the substrate nucleophile, the α-PO4 of the AMP in the second site. This creates the pentavalent intermediate and allows phosphoryl transfer. The proton originally arising from the C8 is then transferred back to C8, allowing the electron density of the adenyl moiety to return to the “ground-state” distribution. The role of the C8-H of AMP in the regulation of the synthesis of ADP is unclear as deuterated AMP has no effect on the reaction (Additional file 1). This site may play a role in the regulation of synthesis of ATP and AMP from two ADP molecules in the reverse reaction using the C8-H of the ADP in the regulation.
Clearly demonstrated in the data is the perceived steady state enzyme activity is mediated via the C8-H of ATP and its transfer via a co-ordinated Thr residue. In both SK and AK1, the SDM of the Thr residue in the ATP binding site caused a loss of control of the enzyme activity as there was a significant change in the vmax. This was also demonstrated by the change in the enzyme activity profile from being hyperbolic to being linear in response to the ATP concentration. As the deuteration of the C8-H has such a significant effect on the binding and steady state kinetics of kinases rationally deuterated imidazole based purine inhibitors should have improved inhibition constants when compared with their non-deuterated analogues especially at low concentrations. This has obvious implications in rational drug design.
Discovery Studio® (Accelrys Inc) was used for all structural bioinformatics and molecular modelling protocols. The structures used were adenylate kinase (2C95.pdb) and shikimate kinase (1L4U.pdb) were obtained from the wwPDB. The AK1 structure contains bis (adenosine)-5′-tetraphosphate (AP5A) and the malonate ion, while the SK contains ADP, 4-(hydroxyethyl)-1-piperzine, Cl- and Mg2+.
Unless otherwise specified, all were chemicals sourced from Merck.
Production and site-directed mutagenesis of AK1 and SK
The Mycobacterium tuberculosis aroK gene, encoding the wild type SK, was obtained from the group of Chris Abell, Cambridge University, UK, in plasmid pBAN0209. A plasmid containing the gene for human AK1 (AK1A-c001) was received from the Structural Genomics Consortium (SGC) in Oxford. Both enzymes contain a N-terminal 6-His purification tag, and were transformed into E. coli BL21(DE3) for IPTG-induced expression. A single colony was inoculated into 50 ml LB + Amp100 and cultivated overnight at 37°C. 2.5 ml of this culture was transferred to 250 ml of the same medium and cultivation continued until OD600 ≅ 0.5-0.8. 250 μl 1 M IPTG (Peqlab Biotechnologie GmbH) was added for induction and the culture grown at 30°C overnight. The biomass from 250 ml culture was harvested, resuspended in 20 ml Binding Buffer (500 mM NaCl, 40 mM Tris pH 7.9) and sonicated for 20 min on a 50% on-off cycle. After centrifugation at 12,000 g for 10 min (4°C), the supernatant was clarified through a 0.45 μm syringe filter and loaded onto the Bio-Rad Profinia Protein Purification System fitted with a Bio-Scale Mini Profinity IMAC cartridge, using the preprogrammed native IMAC affinity-only method. The his-tagged proteins were eluted off the resin with Elution Buffer (300 mM KCl, 50 mM KH2PO4, 250 mM imidazole, pH 8.0). The purity of both enzymes was judged to be at least 90-95% by SDS-PAGE analysis (Additional file 1: Figure S1). AK1 was dialysed into Buffer A (50 mM potassium phosphate pH 7.5, 1.5 mM MgCl2, 120 mM KCl), while SK was dialysed into Buffer B (50 mM Tris pH 7.5, 1 M NaCl). Aliquots were snap-frozen with liquid N2 and stored at -75°C until required.
Oligonucleotide primers used for the site-directed mutagenesis of SK and AK1
5’-phosphorylated primer sets, indicating silently mutated restriction enzyme site (underlined) and new codon (bold)
Restriction enzyme site
T23V-F: 5'-AGGGCGTC CAGTGTGAGAAGA-3'
T23V-R: 5'-TCCCGGATCC AGGCCCA-3'
T39V-F: 5'-CTACACCCACTTAAG CGTC GGGGAC-3'
R97A-F: 5'-ATTGATGGATATC CGGCT GAGGTGC-3'
R97K-F: 5'-ATTGATGGATATC CGAAG GAGGTGCA-3'
R97Q-F: 5'-ATTGATGGATATC CGCAG GAGGTGC-3'
R128A-F: 5'-ACCCAGGCT CTCTTGAAACGCGT AGAGAC-3'
R128K-F: 5'-ACCCAGAAG CTCTTGAAACGCGT AGAGAC-3'
R128Q-F: 5'-ACCCAGCAG CTCTTGAAACGCGT AGAGAC-3'
R132A-F: 5'-ACCCAGCGGCTCCTTAAG GCT GGAGAGACC-3'
R132K-F: 5'-ACCCAGCGGCTCCTTAAG AAA GGAGAGACC-3'
R132Q-F: 5'-ACCCAGCGGCTCCTTAAG CAA GGAGAGACC-3'
K15I-F: 5'-CTGCCGGATCC GGCATA TCCACCAT-3'
K15R-F: 5'-CTGCCGGGATCC GGCAGG TCCACCA-3'
T17I-F: 5'-CTGCCGGGATCC GGCAAGTCCATA ATCGGGCG-3'
T17R-F: 5'-CTGCCGGGATCC GGCAAGTCCAGA ATCGGGCG-3'
R110A-F: 5'-GGCGTGCGCGCA ACCGGCGGC-3'
R110-R: 5'-CTCGGCGGCGGATATC TCCAGGTAG-3'
The synthesis of ATP deuterated at the C8 position (C8D-ATP) was carried out based on the method of [1, 24]. A 20 mM solution of Na2ATP (USB, Affymetrix) in D2O (Sigma) containing 60 mM triethylamine (TEA) was incubated at 60°C for 144 hours. The TEA was removed by twice passing the solution over a Dowex 20 W ion-exchange resin in the acid form. The pH of the solution was adjusted to pH 12 with NaOH prior to the second pass over the resin. The pH of the solution was adjusted to pH 6.3 prior to freeze drying. The extent of the deuteration of the C8 proton was determined by 1 H NMR and mass spectroscopy. The 1H NMR was carried out on a Varian VNMRS 600 MHz NMR in D2O.
Steady-state specific activities were determined in assays containing 50 mM potassium phosphate buffer (pH 6.8), 0.6 mM ATP (USB, Affymetrix) and AMP (Sigma), 1 mM MgCl2 and differing enzyme concentrations, depending on the activity levels of the mutants. The reactions were incubated at 37°C for varying times, again depending on the activity levels of the mutants, before being terminated by the addition of 10 mM EDTA.2Na.2H2O.
ATP/C8D-ATP concentration gradient assays contained 50 mM potassium phosphate buffer (pH 6.8), 3.3 nM (WT AK1, AK1-T23V) or 2 nM (AK1-T39V) enzyme, and varying amounts of AMP, ATP or C8-D ATP, and MgCl2. These were kept at a constant ratio of 1:1:2.2 for AMP: ATP/C8-D ATP: MgCl2. The ATP concentrations ranged between 0.5 and 4 mM. The reactions were incubated at 37°C for varying times, before being terminated by the addition of 10 mM EDTA.2Na.2H2O. Each data point is the average for triplicate reactions. The ADP concentration was measured by HPLC.
Steady-state specific activities were determined in assays containing: 100 mM potassium phosphate buffer (pH 6.8), 500 mM KCl, 1 mM ATP and MgCl2, 2.4 mM shikimic acid (Sigma) and differing enzyme concentrations, depending on the activity levels of the mutants. The reactions were incubated at 37°C for varying times, again depending on the activity levels of the mutants, before being terminated by the addition of 10 mM EDTA.2Na.2H2O. Each data point is the average for triplicate reactions.
ATP/C8D-ATP concentration assays contained 100 mM potassium phosphate buffer (pH 6.8), 500 mM KCl, 8 mM shikimic acid, 10 nM enzyme, and varying amounts of ATP or C8D-ATP, and MgCl2. These were kept at a constant ratio of 1:1 for ATP/C8D-ATP: MgCl2. The ATP concentrations ranged between 0.5 and 10 mM. The reactions were incubated at 30°C for varying times, before being terminated by the addition of 10 mM EDTA.2Na.2H2O. Each data point is the average for triplicate reactions. The ADP concentration was measured by HPLC.
The production of ADP was analysed by HPLC . The assay solutions were centrifuged prior to HPLC analysis. The assays for adenosine, AMP, ADP ATP were carried out using Phenomenex 5 μ LUNA C18 column with the mobile phase containing PIC A® (Waters Coorporation), 250 ml acetonitrile, 7 g KH2PO4 per litre water. The flow rate of the mobile phase was 1 ml/minute with UV detection.
We thank the group of Chris Abell, Cambridge University, UK, for the Mycobacterium tuberculosis aroK gene, encoding the wild type SK, and the Structural Genomics Consortium (SGC) in Oxford for the plasmid containing the gene for human AK1 (AK1A-c001). We thank Dr Chris van der Westhuyzen for valuable comments review of the manuscript. This work was supported by the Council for Scientific and Industrial Research (CSIR) parliamentary grant.
- Kenyon CP, Steyn A, Roth RL, Steenkamp PA, Nkosi TC, Oldfield LC: The role of the C8 proton of ATP in the regulation of phosphoryl transfer within kinases and synthetases. BMC Biochem. 2011, 12: 36-53. 10.1186/1471-2091-12-36.PubMedPubMed CentralView ArticleGoogle Scholar
- Kenyon CP, Roth RL, Westhuyzen CW, Parkinson CJ: Conserved phosphoryl transfer mechanisms within kinase families and the role of the C8 proton of ATP in the activation of phosphoryl transfer. BMC Research Notes. 2012, 5: 131-10.1186/1756-0500-5-131.PubMedPubMed CentralView ArticleGoogle Scholar
- Cheek S, Zhang H, Grishin NV: Sequence and structure classification of kinases. J Mol Biol. 2002, 320: 855-881. 10.1016/S0022-2836(02)00538-7.PubMedView ArticleGoogle Scholar
- Cheek S, Ginalski K, Zhang H, Grishin NV: A comprehensive update of the sequence and structure classification of kinases. BMC Struc. Biol. 2005, 5 (6): 1-19.Google Scholar
- Vonrhein C, Schlauderer GJ, Schulz GF: Movie of the structural changes during a catalytic cycle of nucleoside monophosphate kinases. Structure. 1995, 3: 483-490. 10.1016/S0969-2126(01)00181-2.PubMedView ArticleGoogle Scholar
- Haslam E: Shikimic Acid: Metabolism and Metabolites. 1993, Chichester: WileyGoogle Scholar
- Van Rompay AR, Johansson M, Karlsson A: Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases. Pharmacol Ther. 2000, 87: 189-198. 10.1016/S0163-7258(00)00048-6.PubMedView ArticleGoogle Scholar
- Ren H, Wang L, Bennett M, Lian Y, Zheng X, Lu F, Li L, Nan J, Luo M, Eriksson S, Zhang C, Su X-D: The crystal structure of human adenylate kinase 6: an adenylate kinase localised to the cell nucleus. Proc Natl Acad Sci. 2005, 102: 303-308. 10.1073/pnas.0407459102.PubMedPubMed CentralView ArticleGoogle Scholar
- Fukami-Kobayashi K, Nosaka M, Nakazawa A, Go M: Ancient divergence of long and short isoforms of adenylate kinase: molecular evolution of the nucleoside monophosphate kinase family. FEBS Lett. 1996, 385: 214-220. 10.1016/0014-5793(96)00367-5.PubMedView ArticleGoogle Scholar
- Atkinson DE: Cellular energy metabolism and its regulation. 1979, New York: Academic Press, 85-107.Google Scholar
- Nakazawa A, Yamada M, Tanaka H, Shahjahan M, Tanabe T: Gene structures of three vertebrate adenylate kinase isoenzymes. Prog Clin Biol Res. 1990, 344: 495-514.PubMedGoogle Scholar
- Schulz GE: Cold Spring Harbor Symposium on Quantitative Biology. 1987, 52: 429-439. 10.1101/SQB.1987.052.01.050.View ArticleGoogle Scholar
- Markland FS, Wadkins CL: Adenosine triphosphate-adenosine 5'-monophosphate phosphotransferase of bovine liver mitochondria. I. Isolation and chemical properties. J Biol Chem. 1966, 241: 4124-4135.PubMedGoogle Scholar
- Font B, Gautheron DC: General and kinetic properties of pig heart mitochondrial adenylate kinase. Biochim Biophys Acta. 1980, 611: 299-308. 10.1016/0005-2744(80)90065-0.PubMedView ArticleGoogle Scholar
- Nakazawa A, Yamada M, Tanaka H, Shahjahan M, Tanake T: Isoenzymes. Structure, Function and Use in Biology and Medicine. 1990, Wiley-Liss, New York, 495-514.Google Scholar
- Wiberg KB: The deuterium isotope effect. Chem Rev. 1955, 55: 713-743. 10.1021/cr50004a004.View ArticleGoogle Scholar
- Carey FA, Sundberg RJ: Advanced organic chemistry. Part A. Structure and Mechanisms. 2004, NewYork: Plenum PressGoogle Scholar
- Müller CW, Schlauderer GJ, Reinstein J, Schulz GE: Adenylate kinase motions during catalysis: and energetic counterweight balancing substrate binding. Structure. 1996, 4: 147-156. 10.1016/S0969-2126(96)00018-4.PubMedView ArticleGoogle Scholar
- Ramakrishnan C, Danl VS, Ramasarma T: A conformational anaylsis of walker motif A [GXXXXGKT (S)] in nucleotide binding and other proteins. Protein Eng. 2002, 15: 783-798. 10.1093/protein/15.10.783.PubMedView ArticleGoogle Scholar
- Shi Z, Byeon I-JL, Jiang R-T, Tsai D-W: Mechanism of adenylate kinase. What can be learnt from a mutant enzyme with minor perturbation in kinetic parameters. Biochemistry. 1993, 32: 6450-6458. 10.1021/bi00076a019.PubMedView ArticleGoogle Scholar
- Abele U, Schulz GE: High-resolution structures of adenylate kinase from yeast ligated with inhibitor Ap5A, showing the pathway of phosphoryl transfer. Protein Sci. 1995, 4: 1262-1271. 10.1002/pro.5560040702.PubMedPubMed CentralView ArticleGoogle Scholar
- Müller CW, Schulz GE: Structure of the complex between adenylate kinase from Escherichia coli and the inhibitor AP5A refined at 1.9Å resolution. J Mol Biol. 1992, 224: 159-177. 10.1016/0022-2836(92)90582-5.PubMedView ArticleGoogle Scholar
- Fersht A: Structure and mechanism in protein science: guide to enzyme catalysis and protein folding. 1999, New York: W. H. Freeman & CoGoogle Scholar
- Heller S: 1H NMR studies on deuterium - hydrogen exchange at C-5 in uridines. Biochem Biophys Res Commun. 1968, 32: 998-1001. 10.1016/0006-291X(68)90127-7.PubMedView ArticleGoogle Scholar
- Kabsch W, Sander C: Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983, 22: 2577-2637. 10.1002/bip.360221211.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.